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Abstract. In the medical institutions, more than 50% of the error report is  
related to the administration of pharmaceuticals. And the half of the report is re-
lated to the administration of injectable drug. 
By analyzing the error report, the inducing factor of medication error are  
not only the name similarity (sound alike) and the appearance similarity (look 
alike) of the preparations but also the display of the ingredient amount of the  
injectable drug which has 3 types (“X% YmL”, “Xmg/mL YmL”, and 
“Xmg/YmL”) . 
The difficulty of the calculation seems to differ in these three types of dis-
play. Comparison of the right answer in these three types of display is tried 
for 6 subject groups which are three health care providers (physician, nurse 
and pharmacist) and their students. As a result, the calculation right answer 
percentage was high in "Xmg/YmL", "Xmg/mL YmL" and "X% YmL" in 
turn. 
Keywords: medication error, error inducing factor, display of the ingredient 
amount. 
1   Introduction 
In the medical institutions, more than 50% of the error report is related to the admini-
stration of pharmaceutical preparations. And the half of the report is related to the 
administration of injectable drug (Fig.1). By analyzing the error report, the major 
inducing factors of medication error are the name similarity (sound alike) and the 
appearance similarity (look alike) of the pharmaceutical preparations. 
It is not easy to calculate the right dose of the injectable drug prescribed in clinical 
situation, and the calculation result can not be sufficiently confirmed in emergency 
condition. As a result, the wrong dose can be administered to patients without recog-
nizing calculation error. 
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By reviewing the measure to prevent calculation error in clinical setting, Ministry 
of Health, Labor and Welfare (MHLW) sent the notice to pharmaceutical companies 














Fig. 1. Classification of Error Report in Japanese Medical Institution 
Display the amount and the vo lume o f the active ingredient at 
the container label o f injectable drugs.
ex. Drug A 2%5mL ⇒ Drug A 100mg / 5mL
 
Fig. 2. Notice from MHLW : Reinforcement to Prevent Medication Error ( June 2, 2004 ) 
2   Objective 
The label type of injectable drugs’ strengths for preventing calculation errors is evalu-
ated by comparing the correct answer rates to three label types, which are “X% 
YmL”, “Xmg/mL YmL”, and “Xmg/YmL. 
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Q1  Physician  ordered “Administer 
Xylocaine® 30㎎ , intravenously” .
What “mL” should you administer to 
the patient ?
printed on the label
 
Fig. 3. Calculation Example A 
 
Q2  Physician  ordered “Administer 
Xylocaine® 30㎎ , intravenously”. 
What “mL” should you administer to 
the patient ?
printed on the label
 
Fig. 4. Calculation Example B 
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Q3  Physician  ordered “Administer 
Xylocaine® 30㎎ , intravenously”. 
What “mL” should you administer to 
the patient ?
printed on the label
 
Fig. 5.  Calculation Example C 
3   Method 
In this research, two objects are investigated. 
3.1   Calculation of Dosage in Example Case 
Three label types are showed to three health care providers (physician, nurse, pharma-
cist) and their students by presentation of images on screen for 30 seconds (Table 1, 
Fig.3-5). 
Calculation of the dosage is tried by each health care providers and their students 
within the presentation time (30 seconds). 
3.2   Label Type of New Preparations 
Label type of new preparations marketed after the notice of MHLW was examined 
(June in 2004 – December in 2006). 
4   Results 
4.1   Calculation of Dosage 
The correction rates to “X% YmL” are 25.0% (physicians), 2.6% (nurses), 
35.4%(pharmacists) , “Xmg/mL YmL” are 79.5% (physicians), 36.6% (nurses), 72.6% 
(pharmacists), “Xmg/YmL” are 88.6% (physicians), 51.2% (nurses), 85.2% (pharma-
cists) (Fig.6). 
In all surveyed health care providers, correction rates increased “X% YmL”, 
“Xmg/mL YmL” and “Xmg/YmL” in turn,  significantly(p<0.01, chi-square test). 
And same results were observed in the health care students (Fig.7). 
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Fig. 7. Comparison of Right Calculation Percent in Each Health Care Students (p:chi-square 
value) 
These results indicate the most effective label type to prevent calculation errors 
is “Xmg/YmL” for injectable drugs’ strengths. 
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4.2   Label Type of New Preparations 
The injectable drug which was marketed after the notice was 83 preparations (brand 
based)，and 7 combination preparations, 5 transfusion preparations and 28 solid 
preparations to dissolve before use which can not display "Xmg/YmL" are 43 in 83 
preparations (Fig.8). 
Only 4 of 43 preparations which can display "Xmg/YmL" were displayed in "%", 
and all of these 4 preparations are found "Xmg/YmL" on preparation label together. 










All preparations are  printed
also "Xmg/YmL" on the  labe l.
 
Fig. 8. Label type of new preparations marketed after the notice of MHLW 
5   Conclusion 
The most effective label type of injectable drugs’ strengths for preventing calculation 
error is “Xmg/YmL” in this research, and the most effective “Xmg/YmL” is same as 
the indication in the notice from MHLW on June 4, 2004. 
“Xmg/YmL” label is well accepted to the pharmaceutical companies after the no-
tice of MHLW. 
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